EUVIMEDEUVIMED entdecken
Crossref

Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients

Sarah Sofie Wadland, Lars Simon Rasmussen, Matias Vested

Danish Medical Journal · 2024

DOI: 10.61409/a09230578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Danish Medical Journal, 2024. Verfasst von Sarah Sofie Wadland und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Centre of Head and Orthopaedics, Section 6011, Copenhagen University Hospital - Rigshospitalet, Denmark. Hauptthemen laut MEDLINE: Rocuronium, Neuromuscular Nondepolarizing Agents, Neuromuscular Blockade, Neostigmine. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION. The effect of neuromuscular blocking agents may be reversed by administration of neostigmine, when two twitches are present using train-of-four (TOF) stimulation. However, in elderly patients, limited data are available about when to administer neostigmine. We hypothesised that time to two twitches after TOF (TOF-2) was shorter after rocuronium 0.6 mg/kg than after rocuronium 0.9 mg/kg. Also, we hypothesised that time to TOF-2 would be shorter after rocuronium 0.3 mg/kg than after rocuronium 0.6 mg/kg. METHODS. This was a secondary analysis of 50 elderly patients > 80 years; 16 patients received rocuronium 0.6 mg/kg, another 16 patients received rocuronium 0.9 mg/kg; and, finally, 18 patients received rocuronium 0.3 mg/kg. Patients received total intravenous anaesthesia, and neuromuscular block was monitored with acceleromyography. RESULTS. Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after rocuronium 0.9 mg/kg: 37 min. versus 59 min. (difference: 22 min. (95% confidence intervals (CI): 10 to 33 min.), p = 0.0007). Time to TOF-2 after rocuronium 0.3 mg/kg was shorter than after rocuronium 0.6 mg/kg: 19 min. versus 37 min. (difference: 18 min. (95% CI: 11 to 25 min.), p = 0.00006). However, only 33% of the patients receiving 0.3 mg/kg obtained full effect i.e. TOF-0. CONCLUSION. Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after 0.9 mg/kg and shorter after rocuronium 0.3 mg/kg than after 0.6 mg/kg. FUNDING. This work was supported by departmental sources. TRIAL REGISTRATION. This study was a secondary analysis of two clinical trials. Clinicaltrials.gov (NCT04512313), (NCT03857750).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RocuroniumNeuromuscular Nondepolarizing AgentsNeuromuscular BlockadeNeostigmineAnesthesia Recovery PeriodHumansAged, 80 and overFemaleMaleTime FactorsNeuromuscular MonitoringDose-Response Relationship, DrugAndrostanols

Substanzen

RocuroniumNeuromuscular Nondepolarizing AgentsNeostigmineAndrostanols

Autor:innen und Institutionen

  • Department of Anaesthesiology, Centre of Head and Orthopaedics, Section 6011, Copenhagen University Hospital - Rigshospitalet, Denmark.

Zitieren

APA

Wadland, S. S., Rasmussen, L. S., & Vested, M. (2024). Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients. Danish Medical Journal. https://doi.org/10.61409/a09230578

Vancouver

Wadland SS, Rasmussen LS, Vested M. Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients. Danish Medical Journal. 2024. doi:10.61409/a09230578

BibTeX
@article{Wadland2024,
  author = {Wadland, Sarah Sofie and Rasmussen, Lars Simon and Vested, Matias},
  title = {Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients},
  journal = {Danish Medical Journal},
  year = {2024},
  doi = {10.61409/a09230578}
}
Kostenlos starten →